Page last updated: 2024-10-18

dihydroxyphenylalanine and Neurally Mediated Faint

dihydroxyphenylalanine has been researched along with Neurally Mediated Faint in 1 studies

Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Goldstein, DS	1
Holmes, C	1
Frank, SM	1
Dendi, R	1
Cannon, RO	1
Sharabi, Y	1
Esler, MD	1
Eisenhofer, G	1

Clinical Trials (3)

Trial Overview

Trial	Phase	Enrollment	Study Type	Start Date	Status
Clinical Laboratory Evaluation of Chronic Orthostatic Intolerance[NCT00069693]		200 participants	Observational	2003-09-26	Completed
Propranolol for Syncope With Sympathoadrenal Imbalance[NCT00060866]	Phase 4	24 participants	Interventional	2003-05-31	Completed
Propranolol for Syncope With Sympathoadrenal Imbalance in Children[NCT00093860]	Phase 2	50 participants	Interventional	2004-10-31	Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for dihydroxyphenylalanine and Neurally Mediated Faint

Article	Year
Cardiac sympathetic dysautonomia in chronic orthostatic intolerance syndromes. Circulation, 2002, Oct-29, Volume: 106, Issue:18 Topics: Adrenergic alpha-2 Receptor Antagonists; Adult; Autonomic Nervous System Diseases; Chronic Disease;	2002
Cardiac sympathetic dysautonomia in chronic orthostatic intolerance syndromes. Circulation, 2002, Oct-29, Volume: 106, Issue:18 Topics: Adrenergic alpha-2 Receptor Antagonists; Adult; Autonomic Nervous System Diseases; Chronic Disease;	2002
Cardiac sympathetic dysautonomia in chronic orthostatic intolerance syndromes. Circulation, 2002, Oct-29, Volume: 106, Issue:18 Topics: Adrenergic alpha-2 Receptor Antagonists; Adult; Autonomic Nervous System Diseases; Chronic Disease;	2002
Cardiac sympathetic dysautonomia in chronic orthostatic intolerance syndromes. Circulation, 2002, Oct-29, Volume: 106, Issue:18 Topics: Adrenergic alpha-2 Receptor Antagonists; Adult; Autonomic Nervous System Diseases; Chronic Disease;	2002
Cardiac sympathetic dysautonomia in chronic orthostatic intolerance syndromes. Circulation, 2002, Oct-29, Volume: 106, Issue:18 Topics: Adrenergic alpha-2 Receptor Antagonists; Adult; Autonomic Nervous System Diseases; Chronic Disease;	2002
Cardiac sympathetic dysautonomia in chronic orthostatic intolerance syndromes. Circulation, 2002, Oct-29, Volume: 106, Issue:18 Topics: Adrenergic alpha-2 Receptor Antagonists; Adult; Autonomic Nervous System Diseases; Chronic Disease;	2002
Cardiac sympathetic dysautonomia in chronic orthostatic intolerance syndromes. Circulation, 2002, Oct-29, Volume: 106, Issue:18 Topics: Adrenergic alpha-2 Receptor Antagonists; Adult; Autonomic Nervous System Diseases; Chronic Disease;	2002
Cardiac sympathetic dysautonomia in chronic orthostatic intolerance syndromes. Circulation, 2002, Oct-29, Volume: 106, Issue:18 Topics: Adrenergic alpha-2 Receptor Antagonists; Adult; Autonomic Nervous System Diseases; Chronic Disease;	2002
Cardiac sympathetic dysautonomia in chronic orthostatic intolerance syndromes. Circulation, 2002, Oct-29, Volume: 106, Issue:18 Topics: Adrenergic alpha-2 Receptor Antagonists; Adult; Autonomic Nervous System Diseases; Chronic Disease;	2002